The "LTBP2 Gene Glaucoma Primary Type 3D Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the LTBP2 gene, which have been linked to the development of primary congenital glaucoma (PCG) type 3D. This condition is a rare form of glaucoma that typically presents itself at birth or during the first few years of life, leading to increased intraocular pressure, optic nerve damage, and potentially severe vision loss if not diagnosed and treated early.
The test, priced at 4400 AED, utilizes advanced genetic sequencing techniques to analyze the LTBP2 gene for specific genetic variations known to contribute to this form of glaucoma. By identifying these mutations, healthcare providers can confirm a diagnosis of primary congenital glaucoma type 3D, enabling them to tailor treatment strategies more effectively and provide targeted interventions. Additionally, this test can offer valuable information for family planning and genetic counseling for families affected by this condition.
Performed at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services, the LTBP2 Gene Glaucoma Primary Type 3D Genetic Test represents a crucial tool in the early detection and management of this serious eye condition, ultimately helping to preserve vision and improve the quality of life for those affected.
The "OAT Gene Gyrate Atrophy of Choroid and Retina with or without Ornithinemia Genetic Test" is a specialized diagnostic procedure aimed at detecting mutations in the OAT gene, which are responsible for gyrate atrophy of the choroid and retina. This rare genetic disorder is characterized by progressive vision loss, typically beginning in childhood or adolescence. The condition may also be associated with ornithinemia, an abnormal accumulation of ornithine in the blood due to the body's inability to properly metabolize this amino acid.
Performed at DNA Labs UAE, this genetic test plays a crucial role in the early identification and management of the disorder. By analyzing a sample of the patient's DNA, the test can confirm the presence of specific mutations in the OAT gene, thereby aiding in the diagnosis of gyrate atrophy and guiding treatment decisions. The cost of the test is 4400 AED, reflecting the specialized technology and expertise required to accurately identify the genetic mutations associated with this condition.
Early diagnosis through this genetic test is essential for managing symptoms, slowing the progression of vision loss, and improving the quality of life for affected individuals. It also provides valuable information for family planning and the assessment of risk in future offspring.
The RB1 Gene Hereditary Retinoblastoma Genetic Test is a crucial diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RB1 gene, which are strongly associated with hereditary retinoblastoma. Retinoblastoma is a rare form of eye cancer that predominantly affects young children and can be inherited. Early detection through this genetic testing can be life-saving and significantly influence the management and treatment options for affected individuals and their families.
The test, priced at 4400 AED, involves analyzing the patient's DNA to look for abnormalities in the RB1 gene, which plays a critical role in cell cycle regulation and tumor suppression. By identifying specific mutations in this gene, healthcare providers can assess an individual's risk for developing retinoblastoma and implement appropriate surveillance and preventive measures.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the RB1 Gene Hereditary Retinoblastoma Genetic Test is performed under strict quality control measures, ensuring accurate and reliable results. The test not only aids in the early detection of retinoblastoma but also provides valuable information for family planning and the assessment of risk in siblings and future generations.
The HPS4 gene Hermansky-Pudlak syndrome type 4 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the HPS4 gene, which are responsible for causing Hermansky-Pudlak syndrome (HPS) type 4. This rare genetic disorder is characterized by a lack of pigmentation (albinism), bleeding disorders, and lung and bowel diseases. The test is crucial for early diagnosis, allowing for appropriate management and treatment of the condition.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the HPS4 gene. The results can help in confirming the diagnosis, understanding the severity of the disorder, and informing patients and families about potential complications and the risk of passing the condition to future generations.
The cost of the HPS4 gene Hermansky-Pudlak syndrome type 4 genetic test at DNA Labs UAE is 4400 AED. Given the complexity of the test and the specialized technology and expertise required to interpret the results accurately, the price reflects the comprehensive analysis and detailed report provided to patients or their healthcare providers. This test is an essential tool for individuals with a family history of HPS or related symptoms, guiding their healthcare decisions and improving their quality of life through tailored medical care.
The HPS1 gene Hermansky-Pudlak syndrome type 1 genetic test is a specialized diagnostic tool used to identify mutations in the HPS1 gene, which are indicative of Hermansky-Pudlak syndrome type 1 (HPS1). HPS1 is a rare genetic disorder characterized by a lack of pigmentation (albinism), bleeding disorders, and lung and bowel diseases. It is caused by mutations in the HPS1 gene, which plays a crucial role in the formation and function of lysosomes and related organelles in cells.
This genetic test is vital for the early diagnosis and management of HPS1, allowing for appropriate interventions and treatments to mitigate the symptoms and improve the quality of life for affected individuals. Early diagnosis can also provide valuable information for family planning and genetic counseling for families with a history of the disorder.
The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. DNA Labs UAE employs state-of-the-art technology and highly qualified professionals to ensure reliable and precise testing outcomes, making it a trusted choice for genetic diagnostics in the region.
The AP3B1 gene plays a critical role in the development of Hermansky-Pudlak syndrome type 2 (HPS2), a rare genetic disorder characterized by albinism, bleeding disorders, and pulmonary and intestinal complications. The genetic test for HPS2 through the analysis of the AP3B1 gene is a pivotal step in diagnosing this condition, enabling healthcare professionals to devise appropriate management and treatment strategies for affected individuals.
Conducted at DNA Labs UAE, the test scrutinizes the AP3B1 gene for mutations that lead to HPS2. This comprehensive genetic testing ensures a precise diagnosis, facilitating early intervention and tailored care plans for patients. The cost of the test is set at 4400 AED, reflecting the intricate processes and advanced technology utilized in identifying the genetic alterations associated with this syndrome.
By opting for this genetic test, individuals suspected of having HPS2 or families with a history of the syndrome can gain valuable insights into their genetic makeup, paving the way for informed healthcare decisions and potentially mitigating the impact of the syndrome's symptoms. DNA Labs UAE, with its state-of-the-art facilities and expertise in genetic diagnostics, stands at the forefront of genetic testing services, offering hope and clarity to those affected by Hermansky-Pudlak syndrome type 2.
The Hermansky-Pudlak Syndrome type 3 (HPS3) genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the HPS3 gene. This gene is crucial for the proper formation of lysosomes and related organelles in cells, and mutations can lead to Hermansky-Pudlak syndrome (HPS), a rare autosomal recessive disorder. HPS is characterized by a lack of pigment in the skin, hair, and eyes (albinism), a propensity for bleeding due to platelet abnormalities, and in some cases, lung and bowel diseases. Identifying mutations in the HPS3 gene through this test can provide definitive diagnosis of HPS type 3, enabling targeted management and treatment strategies for affected individuals. The cost of the HPS3 gene test at DNA Labs UAE is 4400 AED, reflecting the specialized nature of this genetic analysis and its significance in providing critical health information.
The "DHH Gene 46XY Gonadal Dysgenesis Partial with Minifascicular Neuropathy Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the DHH gene that are associated with 46XY gonadal dysgenesis partial syndrome accompanied by minifascicular neuropathy. This condition is characterized by underdeveloped gonads in individuals who are genetically male (with one X and one Y chromosome), leading to a range of developmental and reproductive issues. Additionally, the presence of minifascicular neuropathy indicates a neurological component, where nerve fibers are abnormally organized into small bundles or fascicles, potentially causing sensory and motor deficits.
The test is critical for early diagnosis and management of the condition, enabling healthcare providers to offer appropriate treatments and interventions to improve the quality of life of affected individuals. The cost of the test is set at 4400 AED, reflecting the specialized nature of the genetic analysis and the comprehensive insights it provides into the patient's condition. By conducting this test at DNA Labs UAE, patients and their families can access advanced genetic testing services within the region, supported by a team of experts in genetics and molecular diagnostics.
The CACNA1F Gene Cone-rod dystrophy X-linked type 3 Genetic Test is a specialized diagnostic examination aimed at identifying mutations in the CACNA1F gene, which are associated with Cone-rod dystrophy X-linked type 3, a rare genetic disorder. This condition primarily affects the eyes, leading to a progressive loss of vision due to the deterioration of cone and rod cells in the retina. The test is crucial for early diagnosis, allowing for appropriate management and counseling for affected individuals and their families.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific genetic alterations in the CACNA1F gene. The results can provide invaluable information for affected individuals, including insights into the progression of the disease, potential treatments, and the risk of passing the condition on to offspring.
The cost of the CACNA1F Gene Cone-rod dystrophy X-linked type 3 Genetic Test is set at 4400 AED, reflecting the sophisticated technology and expert analysis required to accurately identify mutations in the CACNA1F gene. While the price may seem high, the information gained from this test can be critical for the effective management of Cone-rod dystrophy X-linked type 3, significantly impacting the quality of life for those diagnosed with this challenging condition.
The TGFBI Gene Corneal Dystrophy Epithelial Basement Membrane Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TGFBI gene that are associated with various types of corneal dystrophies, including epithelial basement membrane dystrophy (EBMD). EBMD, also known as map-dot-fingerprint dystrophy, is a common eye condition that can lead to vision impairment due to irregularities in the cornea's epithelial basement membrane. The test plays a crucial role in the accurate diagnosis and management of patients affected by or at risk of developing this condition.
By analyzing the patient's DNA, the test can pinpoint specific genetic mutations in the TGFBI gene, offering valuable insights into the disease's prognosis, potential treatment strategies, and the risk of inheritance for family members. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to conduct this sophisticated genetic analysis. Conducted at DNA Labs UAE, a leading facility in genetic testing, this service ensures high accuracy and reliability, providing essential information for patients and healthcare providers in managing corneal dystrophies effectively.
